Authors: Yamada, Y Tomonaga, M Fukuda, H Hanada, S Utsunomiya, A Tara, M Sano, M Ikeda, S Takatsuki, K Kozuru, M Araki, K Kawano, F Niimi, M Tobinai, K Hotta, T Shimoyama, M

Citation: Y. Yamada et al., A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303, BR J HAEM, 113(2), 2001, pp. 375-382

Authors: Takenaka, T Mikuni, C Miura, A Sasaki, T Suzuki, H Hotta, T Hirano, M Fukuhara, S Sugiyama, H Nasu, K Dohi, H Kozuru, M Tomonaga, M Tajima, K Niimi, M Fukuda, H Mukai, K Shimoyama, M

Citation: T. Takenaka et al., Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905), JPN J CLIN, 30(3), 2000, pp. 146-152

Authors: Shiratsuchi, M Muta, K Umemura, T Nishimura, J Nawata, H Kozuru, M

Citation: M. Shiratsuchi et al., Telomerase activity in myeloma cells is closely related to cell cycle status, but not to apoptotic signals induced by interferon-alpha, LEUK LYMPH, 34(3-4), 1999, pp. 349-359

Authors: Kobayashi, T Tobinai, K Shimoyama, M Mikuni, C Konda, S Kozuru, M Araki, K Sai, T Fukuhara, S Matsumoto, M Aoki, I Deura, K Oyama, A Hotta, T Abe, T Toki, H Nagai, M Fukuda, H Niimi, M Yamaguchi, N Tajima, K Shirakawa, S

Citation: T. Kobayashi et al., Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702, JPN J CLIN, 29(7), 1999, pp. 340-348

Authors: Yufu, Y Goto, T Choi, I Uike, N Kozuru, M Ohshima, K Taniguchi, T Motokura, T Yatabe, Y Nakamura, S

Citation: Y. Yufu et al., A new multiple myeloma cell line, MEF-1, possesses cyclin d1 overexpression and the p53 mutation, CANCER, 85(8), 1999, pp. 1750-1757